GTx is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for treating cancer, for cancer supportive care and for other serious medical conditions. The company’s most advanced drug discovery and development programs are targeted at small molecules that selectively modulate the effects of estrogens and androgens. The company’s headquarters are located in Memphis, Tenn. For more information, visit the company’s Web site at www.gtxinc.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: